IOL Chemicals and Pharmaceuticals Limited (IOLCP.NS)
INR 61.65
(3.88%)
INR 61.65
(3.88%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 4.24 Billion INR | 30.51% |
| 2022 | 3.25 Billion INR | -20.58% |
| 2021 | 4.09 Billion INR | 38.88% |
| 2020 | 2.95 Billion INR | 57.4% |
| 2019 | 1.87 Billion INR | -0.71% |
| 2018 | 1.88 Billion INR | -8.96% |
| 2017 | 2.07 Billion INR | -21.01% |
| 2016 | 2.62 Billion INR | 15.21% |
| 2015 | 2.27 Billion INR | 6.8% |
| 2014 | 2.13 Billion INR | 11.03% |
| 2013 | 1.92 Billion INR | 17.59% |
| 2012 | 1.63 Billion INR | 657.08% |
| 2011 | 215.92 Million INR | -78.31% |
| 2010 | 995.56 Million INR | 48.89% |
| 2009 | 668.65 Million INR | 27.76% |
| 2008 | 523.35 Million INR | 50.7% |
| 2007 | 347.28 Million INR | 14.6% |
| 2006 | 303.04 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 4.24 Billion INR | 0.0% |
| 2023 FY | 4.24 Billion INR | 30.51% |
| 2023 Q2 | 3.16 Billion INR | 0.0% |
| 2023 Q3 | 4.24 Billion INR | 34.33% |
| 2022 FY | 3.25 Billion INR | -20.58% |
| 2022 Q4 | 3.25 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 3.51 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 FY | 4.09 Billion INR | 38.88% |
| 2021 Q4 | 4.09 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 3.02 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 2.95 Billion INR | 57.4% |
| 2020 Q4 | 2.95 Billion INR | 0.0% |
| 2020 Q2 | 2.57 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2019 Q4 | 1.87 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 1.85 Billion INR | 0.0% |
| 2019 FY | 1.87 Billion INR | -0.71% |
| 2019 Q3 | - INR | -100.0% |
| 2018 Q4 | 1.88 Billion INR | 0.0% |
| 2018 Q2 | 1.18 Billion INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 FY | 1.88 Billion INR | -8.96% |
| 2017 Q2 | 2.4 Billion INR | 0.0% |
| 2017 FY | 2.07 Billion INR | -21.01% |
| 2017 Q4 | 2.07 Billion INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q2 | 2.47 Billion INR | 0.0% |
| 2016 Q4 | 2.62 Billion INR | 0.0% |
| 2016 FY | 2.62 Billion INR | 15.21% |
| 2015 Q3 | - INR | -100.0% |
| 2015 FY | 2.27 Billion INR | 6.8% |
| 2015 Q2 | 2.17 Billion INR | 0.0% |
| 2015 Q4 | 2.27 Billion INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q2 | 1.99 Billion INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 Q4 | 2.13 Billion INR | 0.0% |
| 2014 FY | 2.13 Billion INR | 11.03% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q2 | 1.7 Billion INR | 0.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q4 | 1.92 Billion INR | 0.0% |
| 2013 FY | 1.92 Billion INR | 17.59% |
| 2012 FY | 1.63 Billion INR | 657.08% |
| 2012 Q3 | - INR | -100.0% |
| 2012 Q2 | 2.71 Billion INR | 0.0% |
| 2012 Q4 | 1.63 Billion INR | 0.0% |
| 2011 FY | 215.92 Million INR | -78.31% |
| 2010 FY | 995.56 Million INR | 48.89% |
| 2009 FY | 668.65 Million INR | 27.76% |
| 2008 FY | 523.35 Million INR | 50.7% |
| 2007 FY | 347.28 Million INR | 14.6% |
| 2006 FY | 303.04 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 74.151% |
| Hester Biosciences Limited | 755.81 Million INR | -462.099% |
| Aarti Drugs Limited | 4.85 Billion INR | 12.565% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 33.914% |
| Albert David Limited | 436.12 Million INR | -874.133% |
| Alembic Limited | 113.4 Million INR | -3646.384% |
| Alkem Laboratories Limited | 26.61 Billion INR | 84.036% |
| Bafna Pharmaceuticals Limited | 296.41 Million INR | -1333.246% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -194.95% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -16562.352% |
| Brooks Laboratories Limited | 96.1 Million INR | -4320.444% |
| Eris Lifesciences Limited | 1.89 Billion INR | -124.745% |
| FDC Limited | 3.88 Billion INR | -9.245% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 36.267% |
| Gufic Biosciences Limited | 2 Billion INR | -111.909% |
| Hikal Limited | 3.03 Billion INR | -39.879% |
| Ind-Swift Limited | 640.91 Million INR | -562.865% |
| Innova Captab Limited | 1.44 Billion INR | -194.995% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -2732.833% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 67.056% |
| Lincoln Pharmaceuticals Limited | 771.68 Million INR | -450.538% |
| Lupin Limited | 49.53 Billion INR | 91.424% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -243.611% |
| Medico Remedies Limited | 163.37 Million INR | -2500.446% |
| Morepen Laboratories Limited | 2.48 Billion INR | -70.897% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 40.092% |
| Orchid Pharma Limited | 2.64 Billion INR | -60.787% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -289.369% |
| RPG Life Sciences Limited | 1.01 Billion INR | -320.634% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -10552.959% |
| Sigachi Industries Limited | 707.2 Million INR | -500.729% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | -18.11% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | -83.758% |
| Themis Medicare Limited | 705.74 Million INR | -501.976% |
| Unichem Laboratories Limited | 7.04 Billion INR | 39.711% |
| Vaishali Pharma Limited | 3.79 Million INR | -111788.333% |
| Wanbury Limited | 360.23 Million INR | -1079.351% |
| Windlas Biotech Limited | 621.89 Million INR | -583.143% |
| ZIM Laboratories Limited | 812.62 Million INR | -422.797% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -3962.461% |
| Ipca Laboratories Limited | 24.71 Billion INR | 82.809% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 95.695% |
| Venus Remedies Limited | 1.21 Billion INR | -249.117% |
| Sakar Healthcare Limited | 277.32 Million INR | -1431.932% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 95.669% |
| Divi's Laboratories Limited | 31.84 Billion INR | 86.657% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | -86.43% |
| Mankind Pharma Limited | 15.53 Billion INR | 72.652% |
| Sequent Scientific Limited | 3.46 Billion INR | -22.704% |
| Laurus Labs Limited | 18.45 Billion INR | 76.979% |
| Neuland Laboratories Limited | 3.5 Billion INR | -21.237% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 15.456% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 83.095% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 87.657% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -1369.796% |
| Wockhardt Limited | 6.4 Billion INR | 33.619% |
| Bal Pharma Limited | 878.11 Million INR | -383.81% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 93.315% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -258.674% |
| Par Drugs and Chemicals Limited | 41.77 Million INR | -10070.936% |
| Caplin Point Laboratories Limited | 3.63 Billion INR | -17.023% |
| Shilpa Medicare Limited | 3.44 Billion INR | -23.168% |
| Valiant Laboratories Limited | 100.15 Million INR | -4141.868% |
| Ajanta Pharma Limited | 8.28 Billion INR | 48.713% |
| Aarey Drugs & Pharmaceuticals Limited | 346.75 Million INR | -1125.18% |
| Granules India Limited | 13 Billion INR | 67.334% |
| Medicamen Biotech Limited | 593.75 Million INR | -615.518% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -1915.227% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 81.358% |
| NATCO Pharma Limited | 7 Billion INR | 39.352% |
| Suven Life Sciences Limited | 7.08 Million INR | -59863.303% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -4236.695% |
| Strides Pharma Science Limited | 11.26 Billion INR | 62.278% |
| Indoco Remedies Limited | 3.53 Billion INR | -20.331% |
| Alpa Laboratories Limited | 136.65 Million INR | -3008.896% |
| Lasa Supergenerics Limited | 190.43 Million INR | -2130.904% |
| Sun Pharma Advanced Research Company Limited | 14.79 Million INR | -28620.93% |